Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-13-055020
Filing Date
2013-10-11
Accepted
2013-10-11 21:30:52
Documents
1
Period of Report
2013-10-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v357293_4.html 4  
1 OWNERSHIP DOCUMENT v357293_4.xml 4 7258
  Complete submission text file 0001144204-13-055020.txt   8576
Mailing Address 18 Desbrosses Street New York NY 10013
Business Address 18 Desbrosses Street NEW YORK NY 10013 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Issuer) CIK: 0001270073 (see all company filings)

EIN.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 18 DESBROSSES STREET NEW YORK NY 10013
Business Address
TALLARIGO LORENZO (Reporting) CIK: 0001276039 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 131148901